New Mexico Sues Tobacco Companies for Withholding Payments

Dec.01.2022
New Mexico Sues Tobacco Companies for Withholding Payments
New Mexico sues tobacco companies for breach of contract and collusion in withholding annual funds related to 1998 settlement agreement.

New Mexico is currently suing over a dozen tobacco companies in relation to payments associated with a 1998 settlement agreement, alleging collusion and breach of contract.


Balderas alleges that these companies have withheld part of their annual payments according to the multi-state tobacco settlement agreement. According to the attorney general, New Mexico has lost over $84 million in the past 14 years.


These baseless delaying tactics have no end, and it's time to compel tobacco companies to pay the damages they owe to New Mexico – providing funding for critical health initiatives," said Balderrama.


According to a statement from the Prosecutor General's Office, under the settlement agreement, the company is required to make annual payments, but disputes are raised every year, resulting in a certain percentage of payments being withheld, which has led to a possible arbitration process that could take several years.


According to officials, the amount seized is increasing every year. Lawsuits claim that tobacco companies have not disclosed the amount seized or where the seized funds are being held, and that the seizure methods change every year.


According to the lawsuit, this conspiracy is a well-thought-out strategy intended to permanently and deceitfully reduce the amount owed by the defendant under the settlement agreement, and undermine the purpose of the agreement.


2FIRSTS will continue to track and report on this topic, with further updates available on the "2FIRSTSAPP." Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02
Focus on Regulation and Taxation: EVO NXT 2026 Provides Strategic Guidance for Decision-Makers
Focus on Regulation and Taxation: EVO NXT 2026 Provides Strategic Guidance for Decision-Makers
The NGP industry faces rising innovation pressure, growing consumer demand and intensifying regulatory dynamics. Sustainable growth now depends on reliable market intelligence, strong partnerships and structured dialogue with policymakers and stakeholders. On 17–18 April 2026 in Prague, EVO NXT will convene manufacturers, retailers, distributors and industry experts for strategic exchange, with this year’s conference placing regulation and taxation firmly at the center of discussion.
Mar.02
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Vape Club: Over 1.3 Million Illegal E-Cigarettes Seized in UK by 2025, Worth £10 Million on Streets
Vape Club: Over 1.3 Million Illegal E-Cigarettes Seized in UK by 2025, Worth £10 Million on Streets
Vape Club report reveals 1.3 million illegal e-cigarettes seized in UK by 2025, worth £10 million on the streets.
Mar.12 by 2FIRSTS.ai
Singapore hikes vape penalties: users face up to S$10,000; importers up to 9 years
Singapore hikes vape penalties: users face up to S$10,000; importers up to 9 years
Singapore Parliament passes law to significantly increase penalties for e-cigarette possession, use, import, and sale, effective May 1.
Mar.09 by 2FIRSTS.ai
JTI Korea Introduces Ploom AURA With Four Heating Modes and Four Device Colors
JTI Korea Introduces Ploom AURA With Four Heating Modes and Four Device Colors
JTI Korea announced that its next-generation heated tobacco device Ploom AURA will officially launch in South Korea on April 14. The company held a media event on March 31 at the Fairmont Ambassador Seoul Hotel to unveil the product in Korea for the first time.
Apr.01 by 2FIRSTS.ai